Diagnostic pitfalls in syringocystadenocarcinoma papilliferum: Case report and review of the literature

Archives of Pathology and Laboratory Medicine

Volumn 134, Issue 8, 2010, Pages 1205-1209

  Leeborg, Nicky ^a   Thompson, Michele ^b   Rossmiller, Sarah ^b   Gross, Neil ^c   White, Clifton ^b   Gatter, Ken ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b Department of Dermatopathology ^*  (Portugal)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CKAP4 PROTEIN, HUMAN; KERATIN; MEMBRANE PROTEIN; TUMOR MARKER;

AGED; ARTICLE; CANCER INVASION; CASE REPORT; CELL NUCLEUS; CYSTADENOCARCINOMA; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; METABOLISM; PATHOLOGY; SQUAMOUS CELL CARCINOMA; SWEAT GLAND TUMOR; SYRINGOMA; TUMOR RECURRENCE;

AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CELL NUCLEUS; CYSTADENOCARCINOMA, PAPILLARY; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; KERATINS; MEMBRANE PROTEINS; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; SWEAT GLAND NEOPLASMS; SYRINGOMA; TUMOR MARKERS, BIOLOGICAL;

EID: 77955393193     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Bondi R, Urso C. Syringocystadenocarcinoma papilliferum. Histopathology. 1996;28(5):475-477.
2. Dissanayake RV, Salm R. Sweat-gland carcinomas: prognosis related to histological type. Histopathology. 1980;4(4):445-466.
3. Park SH, Shin YM, Shin DH, Choi JS, Kim KH. Syringocystadenocarcinoma papilliferum: a case report. J Korean Med Sci. 2007;22(4):762-765.
4. Patterson JW, Wick MR. Nonmelanocytic Tumors of the Skin. Silver Spring, MD: Armed Registry of Pathology, and Washington, DC: Armed Forces Institute of Pathology; 2006:147-148. Atlas of Tumor Pathology; 4th series, fascicle 4.
5. Ackerman AB, Boer A. Histopathologic Diagnosis of Adnexal Epithelial Neoplasms: Atlas and Text. New York, NY: Ardor Scribendi; 2008:134-135.
6. Arai Y, Kusakabe H, Kiyokane K. A case of syringocystadenocarcinoma papilliferum in situ occurring partially in syringocystadenoma papilliferum. J Dermatol. 2003;30(2):146-150.
7. Ishida-Yamamoto A, Sato K, Wada T, Takahashi H, Iizuka H. Syringocys-tadenocarcinoma papilliferum: case report and immunohistochemical compar-ison with its benign counterpart. J Am Acad Dermatol. 2001;45(5):755-759.
8. Numata M, Hosoe S, Itoh N, Munakata Y, Hayashi S, Maruyama Y. Syringadenocarcinoma papilliferum. J Cutan Pathol. 1985;12(1):3-7.
9. Chi CC, Tsai RY, Wang SH. Syringocystadenocarcinoma papilliferum: successfully treated with Mohs micrographic surgery. Dermatol Surg. 2004;30(3):468-471.
10. Seco Navedo MA, Fresno Forcelledo M, Orduña Domingo A, Junco Petrement P, Soler Sanchez T. Syringocystadenoma papilliferum with malignant evolution: presentation of a case [in French]. Ann Dermatol Venereol. 1982;109(8):685-689.
11. Langner C, Ott A. Syringocystadenocarcinoma papilliferum in situ originating from the perianal skin. APMIS. 2009;117(2):148-150.
12. Kazakov DV, Calonje E, Zelger B, et al. Sebaceous carcinoma arising in nevus sebaceus of Jadassohn: a clinicopathological study of five cases. Am J Dermatopathol. 2007;29(3):242-248.
13. Woestenborghs H, Van Eyken P, Dans A. Syringocystadenocarcinoma papilliferum in situ with pagetoid spread: a case report. Histopathology. 2006;48(7):869-870.
14. Qureshi HS, Ormsby AH, Lee MW, Zarbo RJ, Ma CK. The diagnostic utility of p63, CK5/6, CK 7, and CK 20 in distinguishing primary cutaneous adnexal neoplasms from metastatic carcinomas. J Cutan Pathol. 2004;31(2):145-152.
15. Ivan D, Hafeez Diwan A, Prieto VG. Expression of p63 in primary cutaneous adnexal neoplasms and adenocarcinoma metastatic to the skin. Mod Pathol. 2005;18(1):137-142.
16. Lo Muzio L, Santarelli A, Caltabiano R, et al. p63 overexpression associates with poor prognosis in head and neck squamous cell carcinoma. Hum Pathol. 2005;36(2):187-194.